Pediatric Sacroiliitis: Clinical and Microbiologic Differences Between Infants and Children-Adolescents

Ambra Donzelli1, Eleftheria Samara, Vassiliki Spyropoulou

  • 1From the Department of Pediatrics Orthopedics, Children's Hospital of University Hospitals of Geneva, Geneva.

Insights

Pediatric pyogenic sacroiliitis (PSI) presents differently in infants and children. While Staphylococcus aureus is common in older children, Kingella kingae may cause PSI in infants, requiring specific diagnostic approaches.

Area of Science:

  • Pediatric infectious diseases
  • Pediatric orthopedics
  • Pediatric rheumatology

Background:

  • Pyogenic sacroiliitis (PSI) is a rare but serious infection in children.
  • Understanding age-specific presentations is crucial for timely diagnosis and management.

Purpose of the Study:

  • To investigate the clinical characteristics and outcomes of pediatric pyogenic sacroiliitis (PSI).
  • To compare PSI presentation and etiology between infants and children-adolescents.

Main Methods:

  • A single-center cross-sectional study of 16 pediatric patients diagnosed with PSI.
  • Patients were categorized into infants (6 months-4 years) and children-adolescents (4-16 years).
  • Clinical, laboratory, bacteriologic, and radiologic data were analyzed and compared between groups.

Main Results:

  • Children-adolescents typically presented with limping and pain, with Staphylococcus aureus as the main pathogen.
  • Infants showed ambiguous onset, refusal to bear weight, elevated inflammatory markers, and sterile cultures.
  • A distinct clinical and microbiological profile of PSI was observed in infants.

Conclusions:

  • Pediatric pyogenic sacroiliitis (PSI) may represent distinct conditions in infants versus older children.
  • Kingella kingae is a potential pathogen in infants, contrasting with Staphylococcus aureus in children-adolescents.
  • Oropharyngeal swab PCR for Kingella kingae and MRI are recommended for early diagnosis in infants.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
595
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
306
Appendicitis-I: Introduction01:22

Appendicitis-I: Introduction

The appendix, a small, narrow, blind tube extending from the inferior part of the cecum, is widely regarded as a vestigial organ, having lost much of its original function through evolution. Despite its diminished role, the appendix can become inflamed, a condition known as appendicitis.
Etiology: Appendicitis can arise from various causes, primarily rooted in the obstruction of the appendix lumen. Factors contributing to this obstruction include fecal accumulation, lymphoid hyperplasia and, in...
3.1K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
343
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
637
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
573